SeaSpine Holdings Corporation announced the addition of two experienced leaders in the spine industry to the company's management team. Tyler Lipschultz has been named as Vice President, Orthobiologics and Business Development, effective July 20, 2015. Mr. Lipschultz will be responsible for Orthobiologics marketing and development, as well as business development for all of the company.

Most recently he served as Executive Vice President of NuVasive, including four years Global Operations and prior the Biologics organization. Laetitia Cousin has been named as Vice President, Regulatory, Clinical and Quality Assurance, effective July 27, 2015. Mrs. Cousin has nearly two decades of medical technology experience, primarily in regulatory affairs and quality assurance.

Most recently, she served as Vice President, Regulatory and Clinical Affairs, Quality Assurance. Mr. Lipschultz and Mrs. Cousin will be part of the senior leadership team reporting directly to Keith Valentine, President and Chief Executive Officer.